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ABSTRACT 
5-Fluororaucil (5-FU) as anti-cancer drug was reported to induce thymidine synthase (TS) 
overexpression and cancer cell resistance. To improve its therapeutic efficacy and selective 
targeting, here we developed a targeted delivery system mediated by the active ligand-folate 
receptor chemistry to deliver the 5-FU drug selectively into the tumor microenvironment. The 
preparation was achieved by exploring chitosan (CS)-biopolymer based system with folic 
acid (FA)-conjugation. The 5-FU@FACS-Mn:ZnS quantum dots (QDs) based on the 
histological assessment conducted in the 4T1 challenged mice showed an improved tumor 
remission in the liver, spleen and lungs. The 5-FU@FACS-Mn:ZnS composite induced anti-
proliferative properties in these organs as compared to the free 5-FU drug. Unlike the 5-
FU@FACS-Mn:ZnS treated groups which showed some specific morphological changes 
such as cell shrinkage without obvious presence of adipocytes, the excised section of the 
tumor in the untreated control group and the free 5-FU drug treated group showed necrotic 
and degenerated cells; these cells are multifocally distributed in the tumor mass with 
evidence of widely distributed adipocytes within the tumor mass. These findings suggest that 
the 5-FU@FACS-Mn:ZnS composite has a superior role during the induction of apoptosis in 
the 4T1 cells as compared to the free 5-FU drug treated groups. The results of the study 
therefore suggest that the impregnation of 5-FU anti-cancer drug within the FACS-Mn:ZnS 
system significantly improves its selective targeting efficacy, in addition to improving the 
anti-proliferative properties and attenuate possible tumor resistances to the 5-FU drug. 
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